BUZZELLI et al v. NOVARTIS PHARMACEUTICALS CORPORATION
| LORRAINE BUZZELLI and ANTHONY BUZZELLI |
| NOVARTIS PHARMACEUTICALS CORPORATION |
| 2:2020cv00425 |
| March 26, 2020 |
| US District Court for the Western District of Pennsylvania |
| Arthur J Schwab |
| Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability |
| 28 U.S.C. § 1332 |
| Both |
Docket Report
RSS Track this Docket
This docket was last retrieved on May 21, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 14
TEXT ORDER granting #12 Motion for Robert E. Johnston, Esq to Appear Pro Hac Vice. Signed by Judge Arthur J. Schwab on 5/21/20. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (lck)
|
|
Filing 13
TEXT ORDER granting #11 Motion for Andrew L. Reissaus, Esquire to Appear Pro Hac Vice. Signed by Judge Arthur J. Schwab on 5/21/20. Text-only entry; no PDF document will issue. This text-only entry constitutes the Order of the Court or Notice on the matter. (lck)
|
| Filing 12 MOTION for attorney Robert E. Johnston to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5623136) by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: #1 Declaration, #2 Certificate of Good Standing, #3 Proposed Order) (Johnston, Robert) |
| Filing 11 MOTION for attorney Andrew L. Reissaus to Appear Pro Hac Vice, (Filing fee $70, Receipt # 0315-5622875) by NOVARTIS PHARMACEUTICALS CORPORATION. (Attachments: #1 Declaration, #2 Certificate of Good Standing, #3 Proposed Order) (Reissaus, Andrew) |
|
Filing 10
TEXT ORDER - Revised deadline for filing of 26(f) Report, Proposed Case Management Order, and ADR Stipulation - - fully completed documents are now due to be filed jointly on or before 5/25/20. Signed by Judge Arthur J. Schwab on 05/20/20. Text-only entry; no PDF document will issue. This text-only entry constitutes the Court's order or notice on the matter. (ms)
|
| FINAL NOTICE: In preparation of the Court's conversion to NextGen, our Court's CM/ECF system will be unavailable from 12:00 p.m. (Noon) on Friday, May 22, 2020, until 11:59 pm. Monday, May 25, 2020. Please plan accordingly. Complete information, including a checklist of actions regarding the WDPA NexGen CM/ECF implementation, can be found #here. Preparing for NextGen is a two-step process. The first step is to upgrade any legacy PACER accounts. The second step is to link that upgraded PACER account with your WDPA CM/ECF account after the Court goes live with NextGen. To link your account, you will need your current e-filing credentials from our Court. If your CM/ECF login contains any special characters (anything other than a letter or number), you will need to change it as logins with those characters will be unable to link to PACER accounts. No later than Thursday, May 21, 2020, you should log into both PACER and the current version of CM/ECF to review and record your current e-filing credentials for both, as you will need to know them in order to e-file after May 23, 2020. Please consult the Court's #administrative order for additional information on deadlines and alternative filing options during this period. (Administrator, ) (ADI) |
|
Filing 9
ORDER SETTING Initial Case Management Conference for 6/3/2020 at 09:30 AM by Video Conference before Judge Arthur J. Schwab. 26(f) Report, Proposed Case Management Order, and ADR Stipulation are due 5/26/20. An invitation to connect to the conference by video will be distributed by email to all counsel of record before the hearing. Signed by Judge Arthur J. Schwab on 5/1/20. (lck)
|
| IMPORTANT NOTICE: The United States District Court for the Western District of Pennsylvania will be upgrading its current CM/ECF system to the Next Generation of CM/ECF on May 26, 2020. Complete information, including a checklist of actions regarding the WDPA NexGen CM/ECF implementation, can be found #here. Preparing for NextGen is a two-step process. The first step is to upgrade any legacy PACER accounts. Each attorney must have an individual upgraded PACER account in order to electronically file after our conversion to NextGen. The second step will be to link that upgraded PACER account with your WDPA CM/ECF account after the Court goes live with NextGen. To link your account, you will need your current e-filing credentials from our Court. If your CM/ECF login contains a special character (such as &, @, $, *), you will need to change it as logins with those characters will be unable to link to PACER accounts. No later than Thursday, May 21, 2020, you should log into both PACER and the current version of CM/ECF to (1) review and record your current e-filing credentials for both, as you will need to know them in order to e-file after May 23, 2020 and (2) ensure that your primary email address to receive Notices of Electronic Filings (NEF) is accurate. Failure to provide an accurate email address may result in a delay in receiving NEFs after the Court converts to NextGen. (Administrator, ) (ADI) |
| Filing 8 NOTICE of Appearance by Marie Milie Jones on behalf of NOVARTIS PHARMACEUTICALS CORPORATION. (Jones, Marie) |
| Filing 7 Disclosure Statement identifying Novartis Finance Corporation, a New York corporation; Novartis Corporation, a New York corporation; Novartis Holding, AG, a Swiss company; and Novartis AG, a Swiss company, whose shares are publicly traded on the SIX Swiss Exchange, and whose American Depository Shares are publicly traded on the New York Stock Exchange. as corporate parent or other affiliate, by NOVARTIS PHARMACEUTICALS CORPORATION. (Passodelis, Constantine) |
| Filing 6 ANSWER to #1 Complaint, and Affirmative Defenses by NOVARTIS PHARMACEUTICALS CORPORATION. (Passodelis, Constantine) |
| Filing 5 NOTICE of Appearance by Constantine J. Passodelis on behalf of NOVARTIS PHARMACEUTICALS CORPORATION. (Passodelis, Constantine) |
|
Filing 4
ORDER Re: Federal Rule of Civil Procedure 12(b) Motions to Dismiss. Signed by Judge Arthur J. Schwab on 3/27/20. (ms)
|
| Filing 3 NOTICE that instant civil action has been designated for placement into the United States District Court's Alternative Dispute Resolution program. Parties are directed to fully complete the required 26(f) report, which includes the stipulation of selecting an ADR process. Counsel for plaintiff (or in the case of a removal action, counsel for removing defendant) shall make service of the notice on all parties. (ms) |
| Filing 2 Summons Issued as to NOVARTIS PHARMACEUTICALS CORPORATION. (ept) |
| Filing 1 COMPLAINT against NOVARTIS PHARMACEUTICALS CORPORATION (Filing fee, including Administrative fee, $400, receipt number 0315-5527693), filed by ANTHONY BUZZELLI, LORRAINE BUZZELLI. (Attachments: #1 Civil Cover Sheet, #2 Summons) (ept) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Pennsylvania Western District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
